Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study

Brandon Metra1, Ross Summer2, Sandra Elaine Brooks3

  • 1Department of Radiology, Thomas Jefferson University Hospitals, Philadelphia, United States of America.

Thrombosis Research
|July 18, 2021
PubMed

Insights

Black individuals face higher risks of pulmonary embolism and mortality following COVID-19 infection. This study highlights significant racial disparities in COVID-19 outcomes, particularly concerning pulmonary embolism (PE) and death.

Area of Science:

  • Medical research
  • Public health
  • Epidemiology

Background:

  • Thromboembolism is a known complication of severe COVID-19.
  • Limited research exists on racial disparities in COVID-19-related pulmonary embolism (PE).

Purpose of the Study:

  • To investigate racial disparities in the incidence of pulmonary embolism (PE) and mortality among patients with COVID-19.
  • To analyze the association between race and adverse outcomes following COVID-19 diagnosis.

Main Methods:

  • Retrospective cohort study using a large, multicenter electronic health record dataset (TriNetX).
  • Inclusion of adults diagnosed with COVID-19 between January and September 2020.
  • Propensity matching used to balance sociodemographic and clinical variables between racial groups.

Main Results:

  • Black race was significantly associated with a higher risk of developing PE (RR 1.537) and mortality (RR 1.890) post-COVID-19 diagnosis.
  • Black patients with COVID-19 and PE exhibited a higher mortality rate compared to white patients (RR 1.397).
  • Both racial groups experienced increased mortality with COVID-associated PE compared to COVID-19 or PE alone.

Conclusions:

  • Black race is linked to increased risks of pulmonary embolism and mortality after COVID-19.
  • Racial disparities in COVID-19 outcomes, specifically PE and mortality, are evident, with Black patients facing worse prognoses.
Abstract

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
76
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
200
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
93
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
854
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
877
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.7K